HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Near-Infrared II Nanoadjuvant-Mediated Chemodynamic, Photodynamic, and Photothermal Therapy Combines Immunogenic Cell Death with PD-L1 Blockade to Enhance Antitumor Immunity.

Abstract
The efficacy of immune checkpoint inhibition in inducing death of cancer cells is affected by the immunosuppressive "cold" tumor microenvironment, which results in a poor response by the patient's antitumor immune system. However, the immunomodulatory effects of immunogenic cell death in response to irritation by heat energy and reactive oxygen species (ROS) can switch the tumor microenvironment from "cold" to "hot." This study has developed a nanoadjuvant for immune therapy using iron tungsten oxide (FeWOx)-based nanosheets with surface PEGylation (FeWOx-PEG). This FeWOx-PEG nanoadjuvant serves as a chemodynamic reagent via the Fenton reaction and acts as a photosensitizer for photodynamic and photothermal therapy under near-infrared II laser irradiation; however, it could also be used to augment tumor-infiltrating T-cells and provoke a systemic antitumor immune response by combining the immunogenic cell death triggered by ROS and photothermal therapy with the immune checkpoint blockade. This research demonstrates that application of the FeWOx-PEG nanoadjuvant under the guidance of magnetic resonance/computed tomography/photoacoustic imaging can eliminate the primary tumor and suppress the growth of distant tumors.
AuthorsQinyanqiu Xiang, Chao Yang, Yuanli Luo, Fan Liu, Jun Zheng, Weiwei Liu, Haitao Ran, Yang Sun, Jianli Ren, Zhigang Wang
JournalSmall (Weinheim an der Bergstrasse, Germany) (Small) Vol. 18 Issue 13 Pg. e2107809 (04 2022) ISSN: 1613-6829 [Electronic] Germany
PMID35143709 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Copyright© 2022 Wiley-VCH GmbH.
Chemical References
  • B7-H1 Antigen
Topics
  • B7-H1 Antigen
  • Cell Line, Tumor
  • Humans
  • Immunogenic Cell Death
  • Immunotherapy
  • Phototherapy
  • Photothermal Therapy

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: